Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells
about
PLEKHG2 promotes heterotrimeric G protein βγ-stimulated lymphocyte migration via Rac and Cdc42 activation and actin polymerization.CDC42 Use in Viral Cell Entry Processes by RNA VirusesPhytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancersEssential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicityInvolvement of the Cdc42 pathway in CFTR post-translational turnover and in its plasma membrane stability in airway epithelial cellsHigh glucose levels promote the proliferation of breast cancer cells through GTPases.miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals.MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells.Transforming growth factor β-induced superficial zone protein accumulation in the surface zone of articular cartilage is dependent on the cytoskeleton.A role for activated Cdc42 in glioblastoma multiforme invasion.Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumors in vivo.Interaction of the Small GTPase Cdc42 with Arginine Kinase Restricts White Spot Syndrome Virus in Shrimp.Leptin signaling and cancer chemoresistance: Perspectives.The R-enantiomer of ketorolac delays mammary tumor development in mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice.Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor.
P2860
Q24604472-54659EF5-193B-404D-8FF8-20696C51F737Q26774206-F1469ACF-3DF1-46E3-9651-F28FD82CF2BFQ26798324-AB82BD28-4AE2-4C3F-ADB8-5A570C2E07D2Q28236954-C4DAF9CA-B6D1-4F20-BC9C-0161F65710ECQ28544026-E42A70D3-B1BE-43DC-9F66-475FEA11AB1BQ33821132-266066FE-5317-4E17-BA14-CAE1485BC49AQ35402694-9D37BAB7-D05F-4907-88E1-0BC01A29804EQ36684669-5B67D2D2-6F8A-48AB-AF56-8F24BF0C68EFQ37179748-E184A400-E075-4E17-97A0-B1672EF98C8DQ37610657-67D44DBD-8A10-49F8-82EA-D6FE7AC302C2Q37636732-32844415-81E6-4B8B-A789-5605903CEAD3Q39031194-C2C4DFEA-8D1B-4580-8F2F-0B96AD93766AQ40392295-B7F2CA2D-62ED-41FF-B495-FB824EC052C2Q42365079-E01164F1-3DA5-434F-954F-5F90D9CB85B9Q45324338-0B1BD56B-C4B0-4E96-B608-9FEA2A1D2F17Q55489971-C38AC9E9-E759-4E0B-AD97-AC1D8C42BD4D
P2860
Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of redox/Fyn/c-Cbl ...... basal-like breast cancer cells
@en
type
label
Inhibition of redox/Fyn/c-Cbl ...... basal-like breast cancer cells
@en
prefLabel
Inhibition of redox/Fyn/c-Cbl ...... basal-like breast cancer cells
@en
P2093
P2860
P356
P1476
Inhibition of redox/Fyn/c-Cbl ...... basal-like breast cancer cells
@en
P2093
Brett M Stevens
Hsing-Yu Chen
Mark Noble
Yin M Yang
P2860
P304
P356
10.1002/EMMM.201202140
P577
2013-04-22T00:00:00Z